STRATEC Biomedical AG (SBSG) reported first-half earnings per share of 0.22 euros compared to 0.52 euros, prior year. Adjusted EBIT was at 8.8 million euros compared to 12.8 million euros. Adjusted EBIT margin was 9.8% after 12.7% in the equivalent period of the previous year. The company said the decline in profitability in comparison to the previous year is due particularly to higher expenses in connection with increased development activities and the lower sales volume with the resulting inability to leverage economies of scale. Adjusted earnings per share was 0.61 euros compared to 0.84 euros.
from RTT - Earnings https://ift.tt/2waFv9M
via IFTTT
No comments:
Post a Comment